PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.
Related Research units
Abstract
Preoperative chemotherapy is a recommended treatment of both primary operable and locally advanced breast cancer. Strategies to improve efficacy include the use of anthracyclines, taxanes, and intensified dose with bone marrow support.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 9 |
| ISSN | 0923-7534 |
| Publication status | Published - 2011 |
| pubmed | 21385882 |
|---|
